Go to
JCI Insight
Citations to this article
Sarah A. Smith, … , Hiroshi Nakagawa, Gary D. Wu
Published November 3, 2020
Citation Information: J Clin Invest. 2021;131(1):e133371. https://doi.org/10.1172/JCI133371.
Citation Information: J Clin Invest. 2021;131(1):e133371. https://doi.org/10.1172/JCI133371.
Abstract
As the interface between the gut microbiota and the mucosal immune system, there has been great interest in the maintenance of colonic epithelial integrity through mitochondrial oxidation of butyrate, a short-chain fatty acid produced by the gut microbiota. Herein, we showed that the intestinal epithelium could also oxidize long-chain fatty acids, and that luminally delivered acylcarnitines in bile could be consumed via apical absorption by the intestinal epithelium, resulting in mitochondrial oxidation. Finally, intestinal inflammation led to mitochondrial dysfunction in the apical domain of the surface epithelium that may reduce the consumption of fatty acids, contributing to higher concentrations of fecal acylcarnitines in murine Citrobacter rodentium–induced colitis and human inflammatory bowel disease. These results emphasized the importance of both the gut microbiota and the liver in the delivery of energy substrates for mitochondrial metabolism by the intestinal epithelium.
Authors
Sarah A. Smith, Sayaka A. Ogawa, Lillian Chau, Kelly A. Whelan, Kathryn E. Hamilton, Jie Chen, Lu Tan, Eric Z. Chen, Sue Keilbaugh, Franz Fogt, Meenakshi Bewtra, Jonathan Braun, Ramnik J. Xavier, Clary B. Clish, Barry Slaff, Aalim M. Weljie, Frederic D. Bushman, James D. Lewis, Hongzhe Li, Stephen R. Master, Michael J. Bennett, Hiroshi Nakagawa, Gary D. Wu
Citation information
Citations to this article (40)
| Title and authors | Publication | Year |
|---|---|---|
|
Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation
Xiang F, Zhang Z, Xie J, Xiong S, Yang C, Liao D, Xia B, Lin L |
Journal of Translational Medicine | 2025 |
|
Integrated annotation prioritizes metabolites with bioactivity in inflammatory bowel disease.
Bhosle A, Bae S, Zhang Y, Chun E, Avila-Pacheco J, Geistlinger L, Pishchany G, Glickman JN, Michaud M, Waldron L, Clish CB, Xavier RJ, Vlamakis H, Franzosa EA, Garrett WS, Huttenhower C |
Molecular Systems Biology | 2024 |
|
Sex-specific colonic mitochondrial dysfunction in the indomethacin-induced rat model of inflammatory bowel disease
Hoang N, Brooks K, Edwards K |
Frontiers in physiology | 2024 |
|
Inflammation and Organic Cation Transporters Novel (OCTNs)
Pochini L, Galluccio M, Console L, Scalise M, Eberini I, Indiveri C |
Biomolecules | 2024 |
|
Disruption of intestinal oxygen balance in acute colitis alters the gut microbiome
Zong W, Friedman ES, Allu SR, Firrman J, Tu V, Daniel SG, Bittinger K, Liu L, Vinogradov SA, Wu GD |
Gut microbes | 2024 |
|
Development of a Global Metabo-Lipid-Prote-omics Workflow to Compare Healthy Proximal and Distal Colonic Epithelium in Mice
Hemmati M, Wudy SI, Hackbarth F, Mittermeier-Kleßinger VK, Coleman OI, Haller D, Ludwig C, Dawid C, Kleigrewe K |
Journal of Proteome Research | 2024 |
|
Microbial and Metabolic Gut Profiling across Seven Malignancies Identifies Fecal Faecalibacillus intestinalis and Formic Acid as Commonly Altered in Cancer Patients
Kulecka M, Czarnowski P, Bałabas A, Turkot M, Kruczkowska-Tarantowicz K, Żeber-Lubecka N, Dąbrowska M, Paszkiewicz-Kozik E, Walewski J, Ługowska I, Koseła-Paterczyk H, Rutkowski P, Kluska A, Piątkowska M, Jagiełło-Gruszfeld A, Tenderenda M, Gawiński C, Wyrwicz L, Borucka M, Krzakowski M, Zając L, Kamiński M, Mikula M, Ostrowski J |
International journal of molecular sciences | 2024 |
|
Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent Clostridioides difficile infection.
McMillan AS, Zhang G, Dougherty MK, McGill SK, Gulati AS, Baker ES, Theriot CM |
mSphere | 2024 |
|
Untargeted faecal metabolomics for the discovery of biomarkers and treatment targets for inflammatory bowel diseases.
Vich Vila A, Zhang J, Liu M, Faber KN, Weersma RK |
Gut | 2024 |
|
An untargeted metabolomic study using MALDI-mass spectrometry imaging reveals region-specific biomarkers associated with bowel inflammation
Ponzoni A, Speca S, Hartle M, Gerstenberg A, Tomezyk A, Senechal V, Karnik S, Dubuquoy L, Launay D, Deprez-Poulain R, Gaudin M, Ramos C, Deprez B |
Metabolomics | 2024 |
|
Plasma Bacterial Metabolites in Crohn’s Disease Pathogenesis and Complications
Deskur A, Ambrożkiewicz F, Samborowska E, Błogowski W, Sulikowski T, Białek A, Zawada I, Dąbkowski K, Mitrus J, Karczmarski J, Cybula P, Paziewska A, Starzyńska T |
Nutrients | 2024 |
|
CLUH functions as negative regulator of inflammation in human macrophages and determines ulcerative colitis pathogenesis
Shaziya Khan, Desh Raj, Shikha Sahu, Uday Ghoshal, Amit Lahiri |
JCI Insight | 2023 |
|
Revisiting the “starved gut” hypothesis in inflammatory bowel disease
Colgan SP, Wang RX, Hall CH, Bhagavatula G, Lee JS |
2023 | |
|
Effect of environmental variance-based resilience selection on the gut metabolome of rabbits.
Casto-Rebollo C, Argente MJ, García ML, Blasco A, Ibáñez-Escriche N |
Genetics, Selection, Evolution : GSE | 2023 |
|
Epithelial Nlrp10 inflammasome mediates protection against intestinal autoinflammation.
Zheng D, Mohapatra G, Kern L, He Y, Shmueli MD, Valdés-Mas R, Kolodziejczyk AA, Próchnicki T, Vasconcelos MB, Schorr L, Hertel F, Lee YS, Rufino MC, Ceddaha E, Shimshy S, Hodgetts RJ, Dori-Bachash M, Kleimeyer C, Goldenberg K, Heinemann M, Stettner N, Harmelin A, Shapiro H, Puschhof J, Chen M, Flavell RA, Latz E, Merbl Y, Abdeen SK, Elinav E |
Nature Immunology | 2023 |
|
GPAT3 regulates the synthesis of lipid intermediate LPA and exacerbates Kupffer cell inflammation mediated by the ERK signaling pathway.
Fan G, Li Y, Zong Y, Suo X, Jia Y, Gao M, Yang X |
Cell Death and Disease | 2023 |
|
Sex-specific colonic mitochondrial dysfunction in the indomethacin-induced inflammatory bowel disease model in rats
Hoang N, Brooks K, Edwards K |
Research square | 2023 |
|
Gut Microbiota and Acylcarnitine Metabolites Connect the Beneficial Association between Estrogen and Lipid Metabolism Disorders in Ovariectomized Mice
Guo M, Cao X, Ji D, Xiong H, Zhang T, Wu Y, Suo L, Pan M, Brugger D, Chen Y, Zhang K, Ma B |
Microbiology spectrum | 2023 |
|
NAD+ Metabolism and Immune Regulation: New Approaches to Inflammatory Bowel Disease Therapies
Chen C, Yan W, Tao M, Fu Y |
Antioxidants | 2023 |
|
Faecal metabolome and its determinants in inflammatory bowel disease
Vich Vila A, Hu S, Andreu-Sánchez S, Collij V, Jansen BH, Augustijn HE, Bolte LA, Ruigrok RA, Abu-Ali G, Giallourakis C, Schneider J, Parkinson J, Al-Garawi A, Zhernakova A, Gacesa R, Fu J, Weersma RK |
Gut | 2023 |
|
Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer
Qu R, Zhang Y, Ma Y, Zhou X, Sun L, Jiang C, Zhang Z, Fu W |
Advanced Science | 2023 |
|
Peripheral metabolic alterations associated with pathological manifestations of Parkinson’s disease in gut-brain axis-based mouse model
Huh E, Choi JG, Lee MY, Kim JH, Choi Y, Ju IG, Eo H, Park MG, Kim DH, Park HJ, Lee CH, Oh MS |
Frontiers in molecular neuroscience | 2023 |
|
Epithelial NAD+ depletion drives mitochondrial dysfunction and contributes to intestinal inflammation
Novak EA, Crawford EC, Mentrup HL, Griffith BD, Fletcher DM, Flanagan MR, Schneider C, Firek B, Rogers MB, Morowitz MJ, Piganelli JD, Wang Q, Mollen KP |
Frontiers in immunology | 2023 |
|
Enterobacteriaceae Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel Disease
Lemons JM, Conrad M, Tanes C, Chen J, Friedman ES, Roggiani M, Curry D, Chau L, Hecht AL, Harling L, Vales J, Kachelries KE, Baldassano RN, Goulian M, Bittinger K, Master SR, Liu L, Wu GD |
Cellular and Molecular Gastroenterology and Hepatology | 2023 |
|
Role of Mitochondria in Inflammatory Bowel Diseases: A Systematic Review
Sánchez-Quintero MJ, Rodríguez-Díaz C, Rodríguez-González FJ, Fernández-Castañer A, García-Fuentes E, López-Gómez C |
International journal of molecular sciences | 2023 |
|
Artificial intelligence-rationalized balanced PPARα/γ dual agonism resets dysregulated macrophage processes in inflammatory bowel disease
G Katkar, I Sayed, M Anandachar, V Castillo, E Vidales, D Toobian, F Usmani, J Sawires, G Leriche, J Yang, W Sandborn, S Das, D Sahoo, P Ghosh |
Communications biology | 2022 |
|
Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury
E Rath, D Haller |
Mucosal Immunology | 2022 |
|
Expression of Oxidative Phosphorylation Complexes and Mitochondrial Mass in Pediatric and Adult Inflammatory Bowel Disease
A Schneider, M Özsoy, F Zimmermann, S Brunner, R Feichtinger, J Mayr, B Kofler, D Neureiter, E Klieser, E Aigner, S Schütz, N Stummer, W Sperl, D Weghuber, D Ribeiro |
Oxidative Medicine & Cellular Longevity | 2022 |
|
Chewing the Fat with Microbes: Lipid Crosstalk in the Gut
J Lemons, L Liu |
Nutrients | 2022 |
|
A Preliminary Metabolomic Study of Yorkshire Terrier Enteropathy
A Galler, K Klavins, I Burgener |
Metabolites | 2022 |
|
The association between disruption of the circadian rhythm and aggravation of colitis in mice
Chen YD, Zhao RF, Zheng G, Ling FM, Li JR, Xu MY, Guo D, Zhang QL, Li S, Zhu LR |
Gastroenterology Report | 2022 |
|
Biomarkers of Metabolomics in Inflammatory Bowel Disease and Damp-Heat Syndrome: A Preliminary Study
Wu X, Liu K, Wu Q, Wang M, Chen X, Li Y, Qian L, Li C, Dai G, Zhang Q, Mu G, Wu J, Shan Z |
Evidence-based complementary and alternative medicine : eCAM | 2022 |
|
Metabolic analyses reveal dysregulated NAD+ metabolism and altered mitochondrial state in ulcerative colitis
Kang YH, Tucker SA, Quevedo SF, Inal A, Korzenik JR, Haigis MC |
PloS one | 2022 |
|
Tissue-wide metabolomics reveals wide impact of gut microbiota on mice metabolite composition
Zarei I, Koistinen VM, Kokla M, Klåvus A, Babu AF, Lehtonen M, Auriola S, Hanhineva K |
Scientific Reports | 2022 |
|
Stable isotope tracing in vivo reveals a metabolic bridge linking the microbiota to host histone acetylation.
Lund PJ, Gates LA, Leboeuf M, Smith SA, Chau L, Lopes M, Friedman ES, Saiman Y, Kim MS, Shoffler CA, Petucci C, Allis CD, Wu GD, Garcia BA |
Cell Reports | 2022 |
|
Loss of Mucosal p32/gC1qR/HABP1 Triggers Energy Deficiency and Impairs Goblet Cell Differentiation in Ulcerative Colitis
A Sünderhauf, M Hicken, H Schlichting, K Skibbe, M Ragab, A Raschdorf, M Hirose, H Schäffler, A Bokemeyer, D Bettenworth, AG Savitt, S Perner, S Ibrahim, EI Peerschke, B Ghebrehiwet, S Derer, C Sina |
CMGH Cellular and Molecular Gastroenterology and Hepatology | 2021 |
|
Fat of the Gut: Epithelial Phospholipids in Inflammatory Bowel Diseases
LV Boldyreva, MV Morozova, SS Saydakova, EN Kozhevnikova |
International journal of molecular sciences | 2021 |
|
Reframing Nutritional Microbiota Studies To Reflect an Inherent Metabolic Flexibility of the Human Gut: a Narrative Review Focusing on High-Fat Diets
J Sholl, LJ Mailing, TR Wood, DA Garsin |
mBio | 2021 |
|
Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases
N Gasaly, MA Hermoso, M Gotteland |
International journal of molecular sciences | 2021 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)